Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035783 | SCV000059434 | likely benign | not specified | 2015-04-07 | criteria provided, single submitter | clinical testing | p.Asp778Asp in exon 21 of MYH7: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 26/66694 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs2069544). |
Gene |
RCV000035783 | SCV000170516 | benign | not specified | 2015-01-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000035783 | SCV000248113 | uncertain significance | not specified | 2014-09-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000247521 | SCV000319846 | likely benign | Cardiovascular phenotype | 2015-06-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000556359 | SCV000623666 | likely benign | Hypertrophic cardiomyopathy | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777609 | SCV000913476 | likely benign | Cardiomyopathy | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003320053 | SCV001267860 | uncertain significance | Myosin storage myopathy | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001110424 | SCV001267861 | uncertain significance | Dilated cardiomyopathy 1S | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001110425 | SCV001267862 | benign | MYH7-related skeletal myopathy | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001110426 | SCV001267863 | uncertain significance | Hypertrophic cardiomyopathy 1 | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
CHEO Genetics Diagnostic Laboratory, |
RCV000777609 | SCV001332840 | likely benign | Cardiomyopathy | 2019-12-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001530041 | SCV002497701 | likely benign | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000777609 | SCV004815004 | likely benign | Cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001530041 | SCV001744572 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000035783 | SCV001925176 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001530041 | SCV001930116 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035783 | SCV001954249 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001530041 | SCV001966815 | likely benign | not provided | no assertion criteria provided | clinical testing |